Changes in the (pharma) world during the COVID-19 pandemic
The pharmaceutical industry is subject to constant change. In the last decade, the production of raw materials and activ…
Veränderungen der (Pharma-)Welt in der Covid-19 Pandemie
Die Pharmaindustrie unterliegt einem stetigen Wandel. Insbesondere die Roh- und Wirkstoffproduktion wurde im letzten Jah…
Tentamus Group ruft zum Blutspenden auf
Ungefähr jeder siebte Mensch, der in ein Krankenhaus kommt, benötigt eine Blutspende. Ein Liter Blut kann dabei bis zu d…
Product analytics & market release of hydroxy-chloroquine & chloroquine
Speculation is ongoing that a decade-old malaria drug may be one of the key medications slowing down the spread of the n…
Update on Coronavirus – Tentamus Labs remain open
The Tentamus Group is thoroughly monitoring the COVID-19 pandemic and taking preventative measures to reduce the risk wi…
Update zum Coronavirus – Tentamus Labore bleiben geöffnet
Die Tentamus Gruppe beobachtet die COVID-19-Pandemie gründlich und ergreift vorbeugende Maßnahmen, um das Risiko innerha…
DSI-pharm achieved GMP compliance for 400 MHz-NMR
In October 2020, a complete device qualification of the AscendTM 400 MHz-NMR (Picture 1) used by DSI-pharm was performed…
Determination of nitrosamines – DSI-pharm implements a LC-MS/MS screening method for drug substances and drug products
Since the Valsartan scandal in June 2018, there has been a growing interest in the risk assessment of potential traces o…
Adamson: Stability Shelf Life Testing Special
Adamson Analytical Laboratories is excited to announce that that the capacity for analyses has again been expanded! Sta…
New capabilities on Nitrosamines testing for pharmaceuticals and glass delamination studies at Megsan
Ms. Jyothirmai, Director of Megsan Labs, has announced that Megsan now offers special capabilities to support pharmaceut…
